|
JIVA |
Report of Exempt Distribution |
Other |
07/02/2025 |
 Open Filing (1.55 MB) |
|
CTTT |
Interim MD&A - 1st Quarter September 30, 2024 |
MD&A (Management Discussion and Analysis) |
07/02/2025 |
Open Filing (268.77 KB) |
|
CTTT |
Interim Financial Statements - 1st Quarter September 30, 2024 |
Interim Financial Statements |
07/02/2025 |
Open Filing (356.98 KB) |
|
JIVA |
Report of Exempt Distribution |
Other |
07/02/2025 |
Open Filing (1.55 MB) |
|
CTTT |
Form 5 - 1st Quarter September 30, 2024 |
Quarterly Listing Statement |
07/02/2025 |
Open Filing (625.5 KB) |
|
HEAL |
Restart Life Sciences Corp. Relies on Exception Under CSE Policy 4.6(2)(b) for Previously Closed Private Placement and Debt Settlement Transactions and Announces Debt Settlement Transaction |
Press Release |
07/02/2025 |
Open Filing (78.49 KB) |
|
CTTT |
Form 5 - September 30, 2024 |
Interim Financial Statements |
07/02/2025 |
Open Filing (625.5 KB) |
|
CTTT |
Annual CFO Certificate for YE June 30, 2024 |
Other |
07/02/2025 |
Open Filing (114.98 KB) |
|
ETR |
Monthly Progress Report-Jan 2025 |
Monthly Progress Report |
07/02/2025 |
Open Filing (176.23 KB) |
|
CTTT |
Annual CEO Certificate for YE June 30, 2024 |
Other |
07/02/2025 |
Open Filing (115.58 KB) |
